Головач И.Ю. Бисфосфонаты и атипичные переломы бедра: современное состояние проблемы и ответы на дискуссионные вопросы. Боль. Суставы. Позвоночник. 2012;1(5):62-69.Black D.M., Kelly M.P., Genant H.K. et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur N. Engl. J. Med. 2010; 362:1761-1771.Busse B., Pnemel M., Jobke B., Hahn M., Zustin J., Semlert J., Amling M. Treatment. Histomorphometric and pXRF/EDX analysis of paired iliac crest bone biopsies in 15 patients. J. Bone Miner. Res. 2007; 22 (Suppl. 1):484-485. Abstract W 477.European Medicines Agency concludes class review of bisphosphonates and atypical fractures. Rare atypical fractures of the femur: a class effect of bisphospnates. http://www.ema.europa.eu/docs/en_GB/document_ library/Press_release/2011/04/WC500105281.pdf.Questions and answers on the review of bisphosphonates and atypical stress fractures. http://www.ema.europa. eu/docs/en_GB/document_library/Referrals_ document/Bisphosphonates_31/WC500105287.pdf.Schilcher J., Michaеlsson К., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N. Engl. J. Med. 2011;364:1728-1737.